GRASP

#Thanksgiving reminds us all to be grateful, and GRASP is thankful. We are thankful for the incredible support of this community. We're grateful for the patients, clinicians, and researchers that make GRASP what it is and for their unwavering support and commitment to interacting in a new way to help cancer patients live longer and better lives. #GRASP #thankful

Here's your friendly reminder to register to attend the GRASP Reception at SABCS! Join other GRASP advocates, scientists, and partners as we connect and mingle together on Tuesday, December 10th. #Registertoday #RSVP #GRASP #mixandmingle #reminder #sabcs #sabcs2024

Remember the Alamo... well, kind of ????♀? Remember to register to attend the GRASP Reception at SABCS! Join other GRASP advocates, scientists, and partners as we connect and mingle together on Tuesday, December 10th. #Registertoday #RSVP #GRASP #mixandmingle #reminder #sabcs #sabcs2024

Marlena was a true advocate for individuals facing Metastatic Breast Cancer, especially Black and Brown women, and her vision will continue to the My Style Matters METS Sisterhood. This program has been rebranded in her honor as BLK GRL Metatribe, and it could use your support! Click the link: https://ow.ly/Y7Ye50U5Lwz #GRASPinAction #GRASP #METSSisterhood

Last week, Julia had the privilege of speaking at the National Cancer Institute (NCI) LCBG special event about including patients in cancer research and GRASP's role and impact in this space. Special thanks to Senthil K. Muthuswamy, Ph.D., Glenn Merlino, Ph.D., Debbie Charles Chisholm, and Marylinn Minor for making this a great event! #GRASP #GRASPinAction #GRASPEvents #advocacy #getinvolved National Breast Cancer Coalition

We're a little over a month away from the San Antonio Breast Cancer Symposium, and GRASP is thrilled to be once again putting on our signature Poster Walkthroughs, where advocates and scientists can engage in discussions on research presented SABCS24. Poster Walkthroughs will be held virtually after the conference on Dec 17 and 18 — so save the date and mark your calendars. #SABCS24 #savethedate #STD #PosterWalkthrough #GRASP #GRASPxSABCS

Across the Atlantic, Julia is speaking at 36th EORTC-NCI-AACR Symposium on molecular targets and cancer therapeutics on cancer drug dosing. The Symposium attracts an international audience of academics, scientists and pharmaceutical industry leaders, this event enables discussions on the latest innovations in drug development, target selection and the impact of new discoveries in molecular biology. #GRASPinAction #advocacyinaction #research #EORTCNCIAACR2024

#GRASP co-founders are on the move once again! Today Christine is attending the annual MetNet meeting and giving the patient advocate talk as the Johns Hopkins advocate representative. She's sharing how #PatientAdvocacy can influence #cancerresearch and inspire change. If you happen to be at MetNet —?be sure you listen in! MetNet is advancing the understanding of metastasis as a non-linear, dynamic, and emergent process, as well as revealing mechanistic insights of early dissemination, cellular and physical microenvironment crosstalk, dormancy, and mechanisms of responses by metastatic cells to therapies. The network integrates multiple perspectives and expertise to advance metastasis research, including scientific experts in different fields, physicians, and research advocates — like GRASP! #metnet #graspinaction #johnshopkins #advocacyinaction #metastatic #NCIsysbio24

#tbt to #GRASPinAction at the ABC Global Alliance Report and Charter Steering Committee meeting! Our involvement helps plan future initiatives, and we are honored to offer our insight and expertise. #getinvolved #GRASP #Lisbon #throwback

Join us on Tuesday for our upcoming #GRASPHuddle with Dr. Kelly McCann. She’ll discuss her research and review the poster “An open-label, multicenter, phase 2 study to evaluate the safety and efficacy of BB-1701, a novel antibody drug conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2), in previously treated patients with HER2-positive (HER2+) or HER2-low unresectable or metastatic breast cancer (BC).” Dr. McCann will dive into her exciting new phase 2 study evaluating BB-1701, a novel antibody drug conjugate for patients with HER2-positive and HER2-low metastatic breast cancer that have progressed on Enhertu. Register today! Visit https://lnkd.in/gEs8cjbV or the link in our bio. #huddle #graspcancer #grasphuddles #engage #beyondcancer